Page 26 - Advanced echocardiography in characterization and management of patients with secondary mitral regurgitation

Chapter one. General introduction and outline of thesis
characteristics. Circ Cardiovasc Im-
aging 2014; 7:535-544.
13. Delgado V, Tops LF, Schuijf JD, et al.
Assessment of mitral valve anat- omy and geometry with multislice computed tomography. JACC Car- diovasc Imaging 2009; 2:556-565.
14. Van Mieghem NM, Rodriguez-Ol- ivares R, Ren BC, et al. Computed tomography optimised fluoroscopy guidance for transcatheter mitral therapies. EuroIntervention 2016; 11:1428-1431.
** Comprehensive review crosscor- relating the computed tomography views and the fluorosocopic views for transcatheter procedures for structural heart disease.
15. van Rosendael PJ, van Wijngaarden SE, Kamperidis V, et al. Integrated imaging of echocardiography and computed tomography to grade mitral regurgitation severity in pa- tients undergoing transcatheter aortic valve implantation. Eur Heart J 2017; 38:2221-2226.
** Pioneer study evaluating the feasi- bility of quantification of mitral re- gurgitation with computed tomog- raphy based on the assessment of the 3D vena contracta.
16. Blanke P, Dvir D, Cheung A, et al. A simplified D-shaped model of the mitral annulus to facilitate CT- based sizing before transcatheter mitral valve implantation. J Cardio- vasc Comput Tomogr 2014; 8:459- 467.
17. Theriault-Lauzier P, Mylotte D, Dorfmeister M, et al. Quantitative multi-slice computed tomography assessment of the mitral valvular complex for transcatheter mitral valve interventions part 1: system- atic measurement methodology and inter-observer variability. Euro- Intervention 2016; 12:e1011-e1020.
18. Yoon SH, Bleiziffer S, Latib A, et al. Predictors of Left Ventricular Outflow Tract Obstruction After Transcatheter Mitral Valve Replace- ment. JACC Cardiovasc Interv 2019; 12:182-193.
19. Meduri CU, Reardon MJ, Lim DS, et al. Novel Multiphase Assess- ment for Predicting Left Ventricular Outflow Tract Obstruction Before Transcatheter Mitral Valve Replace- ment. JACC Cardiovasc Interv 2019; 12:2402-2412.
** Important study hihglihgting the importance of standardized com- puted tomgoraphy measurements to define the anatomical suitability for TMVR in patients with mitral valve disease.
20. Kliger C, Jelnin V, Sharma S, et al. CT angiography-fluoroscopy fusion im- aging for percutaneous transapical access. JACC Cardiovasc Imaging 2014; 7:169-177.
21. Blanke P, Dvir D, Naoum C, et al. Pre- diction of fluoroscopic angulation and coronary sinus location by CT in the context of transcatheter mi- tral valve implantation. J Cardiovasc Comput Tomogr 2015; 9:183-192.
22. Baumgartner H, Falk V, Bax JJ, et al. 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 2017; 38:2739- 2791.
23. Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC Focused Up- date of the 2014 AHA/ACC Guide- line for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Associ- ation Task Force on Clinical Practice Guidelines. Circulation. 2017 Jun 20;135(25):e1159-e1195.
24. Garg P, Swift AJ, Zhong L, et al. As- sessment of mitral valve regurgi-
24